United Kingdom Archives

News and Trends 3 Oct 2022

Oxford BioTherapeutics enters into antibody agreement with Genmab

Oxford BioTherapeutics (OBT) says Genmab has licensed a novel antibody related to one of OBT’s IO programs. The target was discovered using Oxford BioTherapeutics’ OGAP drug discovery platform, which incorporates one of the world’s largest proteomic databases, integrating clinical, experimental and expression data. Under the terms of the agreement, Genmab will be responsible for the […]

October 3, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 3 Oct 2022

Redx presents data confirming anti-fibrotic effects of lung disease drug

Redx Pharma has announced preclinical efficacy data in immune mediated models for RXC007. The data on RXC007, its lead fibrosis asset, was presented alongside encouraging final phase 1 safety and pharmacokinetic data at the International Colloquium on Lung and Airway Fibrosis (ICLAF) on October 2 by Nicolas Guisot, research fellow at Redx Pharma. The data […]

October 3, 2022 - 3 minutesmins - By Jim Cornall

Startup Scout 29 Sep 2022

Baseimmune makes future-proof vaccines with AI

Baseimmune is using artificial intelligence (AI) to design vaccines that can protect against future variants of infectious diseases including COVID-19 and malaria. Big data has taken off in the last decade, with dramatic improvements in bioinformatics, data science and AI. These advances allow researchers to store and handle more and more data generated by research […]

September 29, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 29 Sep 2022

Human cells can now help scientists accelerate cure for neurodegenerative diseases

Cell products providing a scalable source of human cells can now help scientists study neurogenerative diseases in human context. UK-based, cell-coding company, bit.bio announced the expansion to its portfolio today (September 29) with disease model, ioGlutamatergic Neurons TDP-43 and early access to its ioMicroaglia cell product. Despite research efforts and funding, bit.bio says the development […]

September 29, 2022 - 3 minutesmins - By Liza Laws

Biodiversity Genomic Europe project will tackle biodiversity crisis

News and Trends 28 Sep 2022

Project to tackle biodiversity crisis using the power of DNA data and genomics launched

A project to tackle the biodiversity crisis using DNA data, genomic science that will fundamentally change conservation science and policy has been launched by European experts. The new pan-European Biodiversity Genomic Europe (BGE) consortium was made public day (September 28) is leading the way with this large-scale application of genomic science. Impacts are predicted to […]

September 28, 2022 - 4 minutesmins - By Liza Laws

News and Trends 28 Sep 2022

Pheon Therapeutics launches with $68M in series A funding for treatment of solid tumors

Pheon Therapeutics launched today (September 28) following the closing of a $68 million series A funding back in March. The investment will allow antibody-drug conjugate (ADC) specialist Pheon to advance its lead ADC program to clinical proof-of-concept and establish of novel ADCs. The financing was led by Brandon Capital, Forbion and Atlas Venture, with participation […]

September 28, 2022 - 3 minutesmins - By Liza Laws

News and Trends 28 Sep 2022

Spoonshot on how foodtech can reduce food waste

With the International Day of Awareness of Food Loss and Waste just around the corner, Labiotech caught up with Spoonshot co-founder and CEO Kishan Vasani to find out how the foodtech sector can tackle food waste. Spoonshot is a software platform for food and beverage professionals that delivers category intelligence by leveraging data from more […]

September 28, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 27 Sep 2022

Watch: Scottish biotech startup looking to sustainable omega-3 production

Established in 2016, Edinburgh-headquartered MiAlgae says there is a global threat to oceans caused by overfishing to supply omega-3 oil for human and animal consumption. This prompted the development of a solution through the circular economy. Labiotech visited the company recently to find out more about its operations. Using its biotech platform, MiAlgae uses co-products […]

September 27, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 27 Sep 2022

Watch: IntelliDigest using biotech to tackle food waste

After obtaining a PhD in environmental engineering, Ifeyinwa Kanu set up IntelliDigest in 2016. Based in Edinburgh, Scotland, at the Heriot-Watt University Business School Incubator, the biotechnology company specializes in food sustainability. The company aims to address the sustainability challenges faced by the entire global food system, including producers, processors, manufacturers, retailers, and consumers. This […]

September 27, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

Research identifies new treatment target for CNS injury and neurological disease

Researchers in Birmingham in the U.K. have identified a potential target for drugs to treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries. The research, published last week in Science Advances, is part of a workstream exploring the signaling pathways that respond to DNA damage, which is seen […]

September 22, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

Promising MND drug slows disease progression

Scientists in the U.K. believe a new genetically-targeted therapy to treat motor neurone disease (MND) could be a turning point for patient care. Results from a phase 3 clinical trial showed significant physical benefits for patients after 12 months. Researchers from the Sheffield Institute for Translational Neuroscience (SITraN) found that patients with a faulty SOD1 […]

September 22, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

New study shows how prostate cancer may start

Researchers at the University of East Anglia in the U.K. say they have made an important discovery about how prostate cancer may start to develop. A new study published in Molecular Oncology reveals that the prostate as a whole, including cells that appear normal, is different in men with prostate cancer. It suggests that tissue […]

September 22, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Oxford BioTherapeutics enters into antibody agreement with Genmab

Redx presents data confirming anti-fibrotic effects of lung disease drug

Baseimmune makes future-proof vaccines with AI

Human cells can now help scientists accelerate cure for neurodegenerative diseases

Project to tackle biodiversity crisis using the power of DNA data and genomics launched

Pheon Therapeutics launches with $68M in series A funding for treatment of solid tumors

Spoonshot on how foodtech can reduce food waste

Watch: Scottish biotech startup looking to sustainable omega-3 production

Watch: IntelliDigest using biotech to tackle food waste

Research identifies new treatment target for CNS injury and neurological disease

Promising MND drug slows disease progression

New study shows how prostate cancer may start

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!